标题 |
A Phase 1b, Double-Blind, Randomized, Placebo Controlled, Multiple Ascending Dose Study of the Safety, Tolerability and Immune Effects of the Intranasal Anti-CD3 Monoclonal Antibody Foralumab in Primary and Secondary Progressive MS
一项1b期、双盲、随机、安慰剂对照、多剂量递增的抗CD3单克隆抗体Foralumab治疗原发性和继发性进行性MS的安全性、耐受性和免疫效应研究
|
网址 | |
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
求助人 | |
下载 |